Stephens began coverage on shares of Enterprise Financial Services (NASDAQ:EFSC – Free Report) in a research note issued to investors on Friday,Benzinga reports. The brokerage issued an equal weight rating and a $70.00 price target on the bank’s stock. Other research analysts have also recently issued research reports about the stock. Weiss Ratings reiterated a […]

JPMorgan Chase & Co. assumed coverage on shares of Prelude Therapeutics (NASDAQ:PRLD – Free Report) in a report released on Thursday, Marketbeat.com reports. The firm issued an overweight rating and a $12.00 target price on the stock. A number of other research firms have also recently weighed in on PRLD. HC Wainwright restated a “buy” […]

Citigroup assumed coverage on shares of FuelCell Energy (NASDAQ:FCEL – Free Report) in a research note released on Tuesday, MarketBeat Ratings reports. The firm issued a neutral rating and a $19.00 price target on the energy company’s stock. Several other equities analysts also recently commented on the stock. Weiss Ratings reiterated a “sell (d-)” rating […]

Stifel Nicolaus started coverage on shares of Cyclerion Therapeutics (NASDAQ:KRSA – Free Report) in a research note issued to investors on Monday, MarketBeat reports. The brokerage issued a buy rating and a $43.00 price target on the stock. KRSA has been the topic of several other reports. UBS Group assumed coverage on Cyclerion Therapeutics in […]

B. Riley Financial initiated coverage on shares of Neuronetics (NASDAQ:STIM – Free Report) in a research report released on Friday, MarketBeat Ratings reports. The firm issued a buy rating and a $5.00 price objective on the stock. A number of other research firms have also weighed in on STIM. BTIG Research reiterated a “buy” rating […]

JPMorgan Chase & Co. started coverage on shares of Ziff Davis (NASDAQ:ZD – Free Report) in a research report released on Friday morning, Marketbeat Ratings reports. The brokerage issued a neutral rating and a $60.00 target price on the technology company’s stock. Several other equities analysts also recently commented on ZD. UBS Group upped their […]

TD Cowen assumed coverage on shares of Sensei Biotherapeutics (NASDAQ:FTH – Free Report) in a report published on Wednesday, MarketBeat.com reports. The firm issued a buy rating on the stock. FTH has been the topic of a number of other research reports. Citigroup assumed coverage on shares of Sensei Biotherapeutics in a research report on […]

Leerink Partners assumed coverage on shares of Collegium Pharmaceutical (NASDAQ:COLL – Free Report) in a research report sent to investors on Wednesday, Marketbeat.com reports. The brokerage issued an outperform rating and a $45.00 target price on the specialty pharmaceutical company’s stock. Other research analysts also recently issued research reports about the stock. Zacks Research downgraded […]

Leerink Partners started coverage on shares of Nautilus Biotechnology (NASDAQ:NAUT – Free Report) in a research note released on Wednesday, MarketBeat.com reports. The brokerage issued an outperform rating and a $4.00 price target on the stock. Separately, Weiss Ratings downgraded Nautilus Biotechnology from a “sell (d-)” rating to a “sell (e+)” rating in a research […]